You’re using a public version of DrugChatter with 10 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.


What is the average number of nivolumab doses?

See the DrugPatentWatch profile for nivolumab

The average number of nivolumab doses cannot be precisely determined as it depends on several factors, including the patient's condition, the dosage prescribed, and the treatment's duration. However, according to the drug label provided by the Food and Drug Administration (FDA) [1], the recommended dose of nivolumab is 240 mg every two weeks or 480 mg every four weeks until disease progression or unacceptable toxicity.

Therefore, the average number of doses can vary significantly from patient to patient. For instance, a patient receiving nivolumab every two weeks would require 12 doses in a year, while a patient receiving it every four weeks would require six doses in a year.

It's important to note that the dosage regimen may vary depending on the specific cancer type and the patient's response to treatment. Healthcare providers make dosage decisions based on the patient's individual needs and the latest clinical guidelines.

[1] U.S. Food and Drug Administration. (2021). Highlights of Prescribing Information: OPDIVO (nivolumab) Injection, for intravenous use [PDF]. Retrieved from
[2] DrugPatentWatch. (n.d.). Nivolumab (OPDIVO). Retrieved from

Other Questions About Nivolumab :  Does insurance status change nivolumab treatment length? How does obesity impact nivolumab s effectiveness? How does gene mutation impact nivolumab s effectiveness?

DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved. Privacy